HEALTHMED, vol.6, no.10, pp.3425-3429, 2012 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, Veterinary Science Database
Osteogenesis imperfecta, pamidronate, bone density, CHILDREN, ALENDRONATE, NERIDRONATE, CHILDHOOD
Sivas Cumhuriyet University Affiliated:
Objective: Osteogenesis imperfecta (OI) is a genetic disorder caused by the mutation in encoding collagen type I, and characterised by fragile bone and reduced bone mineral density. The purpose of this study was to analyse the effects siklik intravenous pamidronate treatment has on the bone mineral density and the fracture rateand mobility.